ANGI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Angi Inc. is not a good buy for a beginner, long-term investor at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Analysts have lowered price targets and expressed concerns about delayed revenue growth recovery. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Holding off on investing in ANGI is the prudent choice given the current data.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. RSI indicates the stock is oversold at 18.716, but MACD is only slightly positive and contracting. The stock is trading below the pivot level of 7.515, with key support at 7.036 and resistance at 7.995. Overall, the technical indicators do not suggest a strong entry point.
NULL identified. No recent news or events suggest a positive catalyst for the stock.
Weak financial performance in Q4 2025, with revenue down 10.12% YoY, net income down 661.74% YoY, and EPS down 666.67% YoY. Analysts have lowered price targets and expressed concerns about delayed revenue growth recovery. The stock is also in a bearish technical trend.
In Q4 2025, revenue dropped to $240.77M (-10.12% YoY), net income dropped to $7.22M (-661.74% YoY), and EPS dropped to $0.17 (-666.67% YoY). However, gross margin increased to 90.87% (+5.20% YoY), which is a minor positive.
Analysts have lowered price targets significantly, with RBC Capital reducing the target to $12 from $18, KeyBanc to $11 from $17, UBS to $11 from $15, Benchmark to $20 from $27, and Truist to $17 from $23. Analysts have expressed concerns about delayed revenue growth recovery and mixed execution.
